and get StockInvest.us Premium Subscription for FREE
Spotify
Google Podcasts
Apple Podcasts
Breaker
Overcast
Pocket Casts
Radio Public
Anchor
ESPR Price Targets and Analyst Ratings NASDAQ:ESPR
Historical Ratings and Targets
| Date | Upside / Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 2022-05-24 | -57.08% | Goldman Sachs | $3.50 $3.00 | Maintains | Sell |
| 2022-05-05 | - | JP Morgan | - | Upgrades | Underweight Neutral |
| 2022-03-10 | 214.74% | HC Wainwright & Co. | $22.00 | Initiates Coverage On | Buy |
| 2022-01-14 | -14.16% | Credit Suisse | $8.00 $6.00 | Maintains | Neutral |
| 2021-12-09 | 71.67% | Needham | $20.00 $12.00 | Maintains | Buy |
| 2021-12-06 | 14.45% | Credit Suisse | $11.00 $8.00 | Maintains | Neutral |
| 2021-12-06 | -28.47% | Goldman Sachs | $8.00 $5.00 | Maintains | Sell |
| 2021-10-19 | 57.37% | Credit Suisse | $28.00 $11.00 | Downgrades | Outperform Neutral |
| 2021-10-14 | 57.37% | Morgan Stanley | $11.00 | Downgrades | Equal-Weight Underweight |
| 2021-08-04 | 143.2% | Morgan Stanley | $22.00 $17.00 | Maintains | Equal-Weight |
| 2021-08-03 | 1530.9% | Needham | $134.00 $114.00 | Maintains | Strong Buy |
| 2021-05-05 | 415.02% | Credit Suisse | $45.00 $36.00 | Maintains | Outperform |
| 2021-05-05 | 186.12% | Stifel | $37.00 $20.00 | Downgrades | Buy Hold |
| 2021-05-05 | 1487.98% | JMP Securities | $191.00 $111.00 | Maintains | Market Outperform |
| 2021-05-05 | 243.35% | Northland Capital Markets | $30.00 $24.00 | Maintains | Market Perform |
| 2021-05-05 | 214.74% | Morgan Stanley | $30.00 $22.00 | Maintains | Equal-Weight |
| 2021-03-11 | 329.18% | Morgan Stanley | $30.00 | Initiates Coverage On | Equal-Weight |
| 2021-02-24 | 1817.02% | Needham | $150.00 $134.00 | Maintains | Strong Buy |
| 2021-02-12 | 329.18% | Jefferies | $40.00 $30.00 | Downgrades | Buy Hold |
| 2021-02-09 | 243.35% | Goldman Sachs | $24.00 | Downgrades | Neutral Sell |
| 2021-01-15 | 400.72% | B of A Securities | $35.00 | Downgrades | Buy Neutral |
| 2020-11-10 | - | Credit Suisse | - | Upgrades | Neutral Outperform |
| 2020-10-15 | 643.92% | B of A Securities | $55.00 $52.00 | Maintains | Buy |
| 2020-08-17 | 686.84% | B of A Securities | $60.00 $55.00 | Maintains | Buy |
| 2020-08-11 | 543.78% | Credit Suisse | $83.00 $45.00 | Downgrades | Outperform Neutral |
| 2020-05-07 | 901.43% | Jefferies | $85.00 $70.00 | Maintains | Buy |
| 2020-04-16 | 500.86% | Northland Capital Markets | $60.00 $42.00 | Maintains | Market Perform |
| 2020-04-01 | 615.31% | B of A Securities | $50.00 | Initiates Coverage On | Buy |
| 2020-03-17 | - | Citigroup | - | Upgrades | Neutral Buy |
| 2020-02-28 | 572.39% | JP Morgan | $46.00 $47.00 | Maintains | Neutral |
| 2020-02-24 | 2160.37% | Needham | $144.00 $158.00 | Maintains | Strong Buy |
| 2020-02-24 | - | Northland Capital Markets | - | Downgrades | Outperform Market Perform |
| 2020-02-14 | 1073.1% | Citigroup | $73.00 $82.00 | Downgrades | Buy Neutral |
| 2019-09-18 | 901.43% | Stifel | $112.00 $70.00 | Maintains | Buy |
| 2019-09-16 | 543.78% | Goldman Sachs | $55.00 $45.00 | Upgrades | Sell Neutral |
| 2019-05-29 | 615.31% | Goldman Sachs | $50.00 | Downgrades | Neutral Sell |
ESPR Stock Trend
The stock lies in the upper part of a very wide and strong rising trend in the short term, and this may normally pose a very good selling opportunity for the short-term trader as reaction back towards the lower part of the trend can be expected. A break-up at the top trend line at $7.09 will firstly indicate a stronger rate of rising.
Given the current short-term trend, the stock is expected to rise 12.69% during the next 3 months and, with a 90% probability hold a price between $5.71 and $7.99 at the end of this 3-month period.
WARNING: Trend forecast is still in the development phase and should be used with caution. Some cases might produce unexpected results such as negative prices at the end of the trend.
Data
| Date | Bottom | Mid | Top |
|---|---|---|---|
| 2022-07-07 | $5.08 | $6.09 | $7.10 |
| 2022-07-08 | $5.09 | $6.10 | $7.12 |
| 2022-07-11 | $5.11 | $6.12 | $7.13 |
| 2022-07-12 | $5.12 | $6.13 | $7.14 |
| 2022-07-13 | $5.13 | $6.14 | $7.16 |
| 2022-07-14 | $5.15 | $6.16 | $7.17 |
| 2022-07-15 | $5.16 | $6.17 | $7.18 |
| 2022-07-18 | $5.17 | $6.18 | $7.20 |
| 2022-07-19 | $5.19 | $6.20 | $7.21 |
| 2022-07-20 | $5.20 | $6.21 | $7.22 |
| 2022-07-21 | $5.21 | $6.22 | $7.24 |
| 2022-07-22 | $5.23 | $6.24 | $7.25 |
| 2022-07-25 | $5.24 | $6.25 | $7.26 |
| 2022-07-26 | $5.25 | $6.26 | $7.28 |
| 2022-07-27 | $5.27 | $6.28 | $7.29 |
| 2022-07-28 | $5.28 | $6.29 | $7.30 |
| 2022-07-29 | $5.29 | $6.30 | $7.32 |
| 2022-08-01 | $5.31 | $6.32 | $7.33 |
| 2022-08-02 | $5.32 | $6.33 | $7.34 |
| 2022-08-03 | $5.33 | $6.34 | $7.35 |
| 2022-08-04 | $5.35 | $6.36 | $7.37 |
| 2022-08-05 | $5.36 | $6.37 | $7.38 |
| 2022-08-08 | $5.37 | $6.38 | $7.39 |
| 2022-08-09 | $5.39 | $6.40 | $7.41 |
| 2022-08-10 | $5.40 | $6.41 | $7.42 |
| 2022-08-11 | $5.41 | $6.42 | $7.43 |
| 2022-08-12 | $5.43 | $6.44 | $7.45 |
| 2022-08-15 | $5.44 | $6.45 | $7.46 |
| 2022-08-16 | $5.45 | $6.46 | $7.47 |
| 2022-08-17 | $5.47 | $6.48 | $7.49 |
Esperion Therapeutics, Inc., a biopharmaceutical company, focuses on the research, development, and commercialization of oral and low-density lipoprotein cholesterol (LDL-C) lowering therapies for the treatment of patients with elevated LDL-C. Its lead product candidate is ETC-1002 or Bempedoic acid, an inhibitor of ATP Citrate Lyase, an enzyme on the cholesterol biosynthesis pathway that is in Phase III long-term safety and tolerability study to... ![StockInvest.us]()
Stock Podcast
Top Fintech Company
featured in The Global Fintech Index 2020 as the top Fintech company of the country.
